SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-14770"
 

Search: onr:"swepub:oai:DiVA.org:uu-14770" > Allopregnanolone se...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Wihlbäck, Anna-CarinUmeå universitet,Obstetrik och gynekologi (author)

Allopregnanolone serum concentrations and neurosteroid sensitivity during withdrawal from postmenopausal hormone therapy

  • Article/chapterEnglish2007

Publisher, publication year, extent ...

  • 2009-07-07
  • Informa UK Limited,2007
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-14770
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-14770URI
  • https://doi.org/10.1080/09513590701550015DOI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-16445URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • BACKGROUND: We have previously compared the pharmacodynamic response to a neuroactive steroid, pregnanolone, before and during sequential treatment with estradiol-only (E2-only) and estradiol together with progesterone (E2 + P) in postmenopausal women. The aim of the present study was to evaluate the pharmacodynamic response to pregnanolone during withdrawal from E2-only treatment and during withdrawal from treatment with E2 + P. METHOD: Twenty-six postmenopausal women were administered hormone therapy (HT) in a randomized, double blinded, placebo-controlled, crossover study. The women received 2 mg oral estradiol continuously during two 28-day cycles and 800 mg vaginal progesterone or placebo sequentially for the last 14 days of each treatment cycle. The pharmacodynamic response to pregnanolone was assessed during the last week of the last treatment cycle and 48 h after termination of the last treatment cycle (withdrawal) by comparing the effects of intravenous pregnanolone (3alpha-hydroxy-5beta-pregnan-20-one) on saccadic eye movements. RESULTS: During E2-only withdrawal the pregnanolone sensitivity was reduced compared with E2-only treatment. Pregnanolone sensitivity remained unaltered between the combined E2 + P treatment regimen and the withdrawal from these steroids. CONCLUSION: The study indicates that withdrawal from E2-only treatment might change neurosteroid sensitivity, whereas the immediate withdrawal from E2 + P results in unchanged neurosteroid sensitivity.

Subject headings and genre

  • Allopregnanolone
  • Hormone therapy
  • Neuroactive steroid
  • Progesterone
  • Saccadic eye velocity
  • Withdrawal
  • MEDICINE
  • MEDICIN

Added entries (persons, corporate bodies, meetings, titles ...)

  • Nyberg, SigridUmeå universitet,Obstetrik och gynekologi(Swepub:umu)sidnyg04 (author)
  • Andersson, AgnetaUmeå universitet,Obstetrik och gynekologi(Swepub:umu)agan0001 (author)
  • Bixo, MarieUmeå universitet,Obstetrik och gynekologi(Swepub:umu)mabi0001 (author)
  • Bäckström, TorbjörnUmeå universitet,Obstetrik och gynekologi(Swepub:umu)toba0001 (author)
  • Sundström-Poromaa, IngerUmeå universitet,Uppsala universitet,Institutionen för kvinnors och barns hälsa,Klinisk och experimentell reproduktionsbiologi/Olovsson,Obstetrik och gynekologi(Swepub:uu)inspo702 (author)
  • Umeå universitetObstetrik och gynekologi (creator_code:org_t)

Related titles

  • In:Gynecological Endocrinology: Informa UK Limited23:10, s. 590-5960951-35901473-0766

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view